ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Wall Street Raises Chips, Beauty, and Brokers

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Analysts lifted targets across several sectors today. Micron Technology saw the boldest move. The consensus target jumped from $945 to $1,009 — a 6.7% increase. The memory chip maker carries a $1.3 trillion market cap. Thirty-eight analysts hold Buy ratings against just one Sell.

Incyte Corporation picked up an upgrade from Truist Securities. The biotech's target rose to $105 from $103. The consensus also shifted higher, with one Hold converted to a Buy. Short interest sits at 6.5% of free float — modest for a biotech name.

Goldman Sachs initiated Estée Lauder with a Buy rating and a $100 target. The cosmetics giant has struggled over the past two years. Goldman's call signals confidence in a recovery. Fourteen analysts currently hold Hold ratings, so the bullish initiation stands out.

Robinhood Markets also received a target price upgrade. The consensus average moved to $101.24 from $101.15. At an $85 billion market cap, the fintech broker has grown sharply. Analyst sentiment remains firmly bullish with 19 Buy ratings and just three Sells.

Bank of America rounded out the upgrades with a target lift to $63.34. The banking giant holds the broadest analyst coverage in today's batch.

Stocks in this article

How this article was generated

Generated
23 Jun 2026, 00:20
Prompt version
v1.0
Data sources
Analyst consensus

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.